Invention Grant
- Patent Title: Pharmaceutical composition for prevention and/or treatment of urinary incontinence
-
Application No.: US15509394Application Date: 2015-09-09
-
Publication No.: US09987279B2Publication Date: 2018-06-05
- Inventor: Shinobu Mori , Yusuke Kajihara , Hiroko Inamura , Takuya Hirata
- Applicant: ASTELLAS PHARMA INC. , CYTOKINETICS INCORPORATED
- Applicant Address: JP Chuo-ku US CA South San Francisco
- Assignee: ASTELLAS PHARMA INC.,CYTOKINETICS INCORPORATED
- Current Assignee: ASTELLAS PHARMA INC.,CYTOKINETICS INCORPORATED
- Current Assignee Address: JP Chuo-ku US CA South San Francisco
- Agency: Oblon, McClleland, Maier & Neustadt, L.L.P.
- Priority: JP2014-183434 20140909
- International Application: PCT/JP2015/075567 WO 20150909
- International Announcement: WO2016/039367 WO 20160317
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/40 ; A61K31/136 ; C07D401/14
Abstract:
The problem to be solved by the present invention is to provide a novel pharmaceutical composition for prevention and/or treatment of urinary incontinence, which differs from conventional drugs. The present invention provides a therapeutic agent for prevention and/or treatment of urinary incontinence having 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1H-pyrrole-3-carboxamide or a salt thereof, as an active ingredient.
Public/Granted literature
- US20170273979A1 NOVEL PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF URINARY INCONTINENCE Public/Granted day:2017-09-28
Information query
IPC分类:
